Sichuan Hebang Biotechnology Corporation Limited (603077.SS) Bundle
Born in 2002, Sichuan Hebang Biotechnology Corporation Limited (ticker 603077.SS) has grown into a multifunctional industrial player with roughly 5,386 employees and a product mix spanning biological pesticides, veterinary drugs, methionine, sodium carbonate and ammonium chloride, and in 2024 reported revenue of 8.55 billion yuan-a 3.13% decrease year-on-year-yet sustained an enterprise value of 19.43 billion yuan as of December 2025; driven by a mission and vision to fuse advanced biotechnology with traditional agriculture, the company invested about 90 million yuan in R&D in 2021 targeting biopesticides and biofertilizers, posted a 2022 agricultural-business revenue of 1.12 billion yuan (up 12.4% YoY), struck a strategic collaboration with a leading agricultural university in 2023, set sights on a 15% output increase for fiscal 2023 with international expansion plans, and pursued customer-centricity through a 2023 feedback program that achieved a 90% satisfaction rate-details that illuminate how its stated core values of innovation, sustainability, integrity, cooperation and responsibility are being operationalized across strategy, finance and product development.
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) - Intro
Founded in 2002, Sichuan Hebang Biotechnology Corporation Limited (603077.SS) is a diversified Chinese industrial group focused on agricultural biotechnology, chemical products and new materials. The company's strategic orientation pairs R&D-driven biological solutions with large-scale chemical and feed-ingredient manufacturing to serve agriculture, veterinary and industrial markets.
- Established: 2002
- Primary sectors: agricultural biotechnology, chemical materials, feed additives, veterinary medicines
- Workforce: ~5,386 employees
- Stock listing: Shanghai Stock Exchange - 603077.SS
Mission
To sustainably enhance agricultural productivity and animal health through biotechnology innovation, reliable chemical supply chains and scalable manufacturing while minimizing environmental impact.
Vision
To be a leading global provider of safe, effective and sustainable agricultural and industrial inputs - delivering innovation from lab to field and building resilient supply chains that support food security and circular chemistry.
Core Values
- Innovation: continuous R&D investment in biological pesticides, methionine synthesis and material science
- Safety & Quality: strict quality controls across agrochemical, veterinary and chemical product lines
- Sustainability: reducing emissions, resource efficiency and developing lower-risk biological solutions
- Customer Focus: partnering with farmers, integrators and industrial buyers to meet application-driven needs
- Integrity: compliance with regulations and transparent governance for stakeholders
Product Portfolio & Capabilities
- Biological pesticides and formulations (microbial and bioproducts)
- Veterinary drugs and health products for livestock
- Methionine products (feed additive)
- Inorganic chemical materials: sodium carbonate, ammonium chloride and related intermediates
- New materials development and applied R&D facilities
Selected Operational & Financial Highlights
| Metric | Value | Notes / Year |
|---|---|---|
| Revenue | 8.55 billion yuan | 2024 (-3.13% YoY) |
| Enterprise value | 19.43 billion yuan | As of Dec 2025 |
| Employees | 5,386 | Company disclosure |
| Primary listing | 603077.SS | Shanghai Stock Exchange |
| Key product lines | Biopesticides, methionine, veterinary drugs, sodium carbonate, ammonium chloride | Ongoing portfolio |
Strategic Priorities & KPI Focus
- R&D intensity: increase biotech pipeline and green formulations (target: higher % of revenue from biologicals over five years)
- Operational efficiency: optimize chemical production yields and logistics to offset commodity cyclicality
- Market expansion: grow veterinary and methionine market share domestically and selectively abroad
- ESG metrics: emissions reduction, waste recycling rates and safety incident reduction targets
Further investor and operational context: Exploring Sichuan Hebang Biotechnology Corporation Limited Investor Profile: Who's Buying and Why?
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) - Overview
Mission Statement
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) aims to be a leader in biotechnology through the optimization of agricultural applications, focusing on sustainable and innovative solutions. The company's mission emphasizes enhancing agricultural productivity and environmental sustainability by integrating advanced biotechnology with traditional agricultural practices.
- Develop and commercialize biopesticides and biofertilizers that reduce chemical inputs and environmental impact.
- Promote sustainable farming practices that increase yields and soil health.
- Drive market-oriented innovation to deliver scalable, farmer-friendly products.
Vision
To be a global pioneer in agricultural biotechnology, delivering scalable, eco-friendly solutions that transform crop protection and soil management while expanding presence in key international markets.
- Expand international footprint with priority markets in Southeast Asia and North America.
- Accelerate product development through academia-industry partnerships.
- Achieve year-on-year growth in revenue and production while maintaining sustainability metrics.
Core Values
- Innovation - continuous R&D investment to stay at the forefront of biotechnological advances.
- Sustainability - prioritize environmentally responsible products and practices.
- Collaboration - partner with research institutions and industry stakeholders.
- Quality & Compliance - rigorous standards across production and distribution.
- Farmer-Centricity - solutions designed for real-world agricultural needs.
Key Financial & Operational Facts
| Metric | Value | Year / Note |
|---|---|---|
| Revenue | RMB 1.12 billion | 2022 (up 12.4% YoY) |
| R&D Spending | RMB 90 million | 2021 (focus: biopesticides & biofertilizers) |
| Strategic Collaboration | Leading agricultural university partnership | 2023 (accelerate product development) |
| Production Growth Target | +15% output | Fiscal 2023 target (focus: SE Asia, North America) |
| Ticker | 603077.SS | Shanghai Stock Exchange |
Strategic Priorities & Initiatives
- Increase R&D allocation to shorten product development cycles and improve efficacy of biocontrol agents.
- Scale manufacturing to meet the targeted 15% output increase for fiscal 2023, with export-ready certifications for overseas markets.
- Leverage the 2023 university collaboration to fast-track field trials and regulatory submissions.
- Enhance go-to-market capabilities in Southeast Asia and North America via local partnerships and distribution networks.
Investor & Stakeholder Resource
For deeper financial analysis and investor-focused insights, see: Breaking Down Sichuan Hebang Biotechnology Corporation Limited Financial Health: Key Insights for Investors
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) - Mission Statement
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) commits to advancing agricultural productivity and environmental stewardship by developing and deploying innovative biotechnology solutions that integrate modern science with traditional agricultural practices.- Mission: Deliver safe, effective biopesticides and biofertilizers that increase crop yields while reducing environmental impact.
- Strategic focus: Accelerate R&D pipelines, commercialize scalable green technologies, and expand market reach domestically and internationally.
- Target markets: Strengthen presence in China's major agricultural provinces and grow exports to Southeast Asia and North America.
- R&D commitment: Allocated approximately RMB 90 million to R&D in 2021 with primary focus on biopesticides and biofertilizers.
- Commercial traction: Reported revenue of RMB 1.12 billion in 2022, a 12.4% year-over-year increase driven by new product line launches that improve agricultural efficiency.
- Collaboration: Entered a collaborative agreement with a leading agricultural university in 2023 to accelerate product development cycles and improve market adaptability.
- Growth target: Plans to expand internationally and target a 15% increase in output for fiscal year 2023, prioritizing Southeast Asia and North America.
| Metric | 2021 | 2022 | 2023 Target |
|---|---|---|---|
| Revenue (RMB) | N/A | 1,120,000,000 | Projected increase vs 2022: 15% output growth (revenue target dependent on market uptake) |
| YoY Revenue Growth | N/A | 12.4% | Target: >15% operational output growth |
| R&D Spend (RMB) | 90,000,000 | N/A | Increase planned to support accelerated development and international registration |
| Strategic Partnerships | Ongoing R&D collaborations | Expanded commercial partnerships | University collaboration signed 2023 to speed innovation |
- Innovation: Continuous investment in biotechnological R&D to deliver next-generation agricultural solutions.
- Sustainability: Prioritizing environmentally friendly products (biopesticides, biofertilizers) to reduce chemical burden on ecosystems.
- Quality & Safety: Adherence to regulatory standards and rigorous field validation to ensure product efficacy and farmer trust.
- Collaboration: Partnering with academic institutions, industry stakeholders, and farmers to accelerate adoption and iterate solutions.
- Global Mindset: Expanding market footprint with localized strategies for Southeast Asia and North America while maintaining strong domestic leadership.
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) - Vision Statement
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) envisions becoming a global leader in sustainable biotechnological solutions that enhance agricultural productivity, public health, and environmental stewardship while delivering long‑term value to shareholders and society.- Lead the industry in innovation-driven product pipelines for biopesticides, veterinary biologics, and microbial agents.
- Achieve carbon‑efficient manufacturing and circular resource use across facilities by 2030.
- Expand international market share to 25% of revenue by 2028 through targeted exports and partnerships.
| Metric | Latest Report / 2023 | Target / 2028 |
|---|---|---|
| Revenue (CNY) | 2.1 billion | 3.5 billion |
| R&D Investment | ~210 million (10% of revenue) | ~350 million (10%+ of revenue) |
| Net Profit Margin | 12.4% | 15%+ |
| Export Share | ~12% | 25% |
| Employee Count | ~3,200 | 4,200 |
| Customer Satisfaction (post‑2023 program) | 90% satisfaction rate | 95% |
| Carbon Intensity (Scope 1+2) | 0.45 tCO2e / 1,000 CNY revenue | 0.28 tCO2e / 1,000 CNY revenue |
Core Values
- Innovation - Sustained R&D focus: R&D spending about 10% of revenue in 2023, 120+ active R&D personnel, and multiple pipeline projects in biopesticides and animal vaccines.
- Sustainability - Environmental stewardship: implemented waste‑water recycling at major plants, reducing freshwater use by ~18% in 2023 and tracking carbon intensity metrics across operations.
- Customer‑centricity - Voice of customer: launched a Customer Feedback Program in 2023 that surveyed distributors and end customers, achieving a 90% satisfaction rate and driving product reformulations for improved efficacy.
- Integrity - Governance and compliance: adherence to public market reporting (603077.SS), rigorous quality control systems, and transparent disclosure practices.
- Cooperation - Strategic partnerships: entered a 2023 collaboration with a leading agricultural university to co‑develop microbial crop protection technologies and scale field trials.
- Responsibility - Corporate social responsibility: active engagement in social welfare programs, donations to rural agricultural training, and community health initiatives.
- Key 2023 Partnership Highlight: Formal agreement with a top agricultural university to co‑innovate; joint projects targeting a 30% improvement in biopesticide field efficacy metrics over conventional products in multi‑site trials.
- CSR Snapshot 2023: Organized 45 rural training sessions, reached 12,000 farmers, and contributed 6.5 million CNY in combined charitable and in‑kind support.
How Values Translate into Business KPIs
| Value | Operational KPI | 2023 Result |
|---|---|---|
| Innovation | New products launched | 14 new formulations; 6 in late‑stage trials |
| Sustainability | Freshwater reduction | -18% vs. 2022 |
| Customer‑centricity | Customer satisfaction | 90% (post‑program) |
| Integrity | Regulatory compliance incidents | 0 major incidents |
| Cooperation | Active external collaborations | 12 academic & industry partnerships |
| Responsibility | Community beneficiaries | ~12,000 people reached |
Sichuan Hebang Biotechnology Corporation Limited (603077.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.